Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,750 | 51,670 | 59,224 | 65,495 | 34,395 |
| TOTAL | $51,518 | $54,764 | $61,297 | $68,529 | $38,085 |
| Non-Current Assets | |||||
| PPE Net | 12,330 | 12,330 | 12,329 | 12,316 | 12,318 |
| Other Non-Current Assets | 18 | 18 | 18 | 18 | 18 |
| TOTAL | $12,348 | $12,348 | $12,347 | $12,334 | $12,336 |
| Total Assets | $63,866 | $67,112 | $73,644 | $80,863 | $50,421 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,154 | 6,375 | 8,578 | 6,802 | 4,723 |
| Accrued Expenses | 3,644 | 1,755 | 1,260 | 1,394 | 2,653 |
| Other current liabilities | 172 | 238 | 276 | 213 | 406 |
| TOTAL | $10,970 | $8,368 | $10,114 | $8,409 | $7,782 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,607 | 12,077 | 10,008 | 11,475 | 12,896 |
| TOTAL | $10,607 | $12,077 | $10,008 | $11,475 | $12,896 |
| Total Liabilities | $21,577 | $20,445 | $20,122 | $19,884 | $20,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | 14 | 14 | 14 | 14 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -193,468 | -188,267 | -180,463 | -172,045 | -164,727 |
| TOTAL | $42,289 | $46,667 | $53,522 | $60,979 | $29,743 |
| Total Liabilities And Equity | $63,866 | $67,112 | $73,644 | $80,863 | $50,421 |